Astrogen, inc.

Astrogen, Inc. is a pioneering biotechnology research company dedicated to advancing healthcare through the development of innovative small molecule therapies. Specializing in neurological and rare diseases, Astrogen, Inc. is committed to addressing unmet medical needs and improving patient outcomes. The company focuses on research and development in areas such as Autism Spectrum Disorder (ASD), ADHD, and other neurodevelopmental conditions.

Based in South Korea, Astrogen, Inc. operates with a vision to translate cutting-edge research into effective treatments. With headquarters in Daegu and additional facilities in Seoul, Astrogen, Inc. is strategically positioned to leverage its expertise and resources. The company’s commitment to innovation drives its efforts to create impactful therapies that make a difference in the lives of individuals and families affected by neurological disorders.

Astrogen, Inc. is poised for continued growth and success in the biotechnology sector. The company’s dedication to scientific excellence and patient-centric solutions positions it as a leader in the development of novel therapeutics. We invite the manager of Astrogen, Inc. to create a customized and exclusive company showcase and product listing on our platform to further enhance your company's visibility and commercial development.